Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder | MicrobiomeTrials← Back to trialsNCT05626959
Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
CompletedPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2022-11-30Est. Completion: 2024-03-01
Enrollment target: 54 participants Locations- Monash Children's Hospital, Clayton, Victoria, Australia
Other microbiome trials you might be interested in
Autism Spectrum DisorderSibling Relations
The purpose of this study was to evaluate the effectiveness of a novel psychoeducational program for adult siblings of a…
Heraklion, GreeceCompleted Oct 30, 2024
AutismDepressedDepressed Mood
Autism spectrum disorder is characterized by differences in social communication/interaction and the presence of restric…
Stony Brook, United StatesEst. completion Sep 2027